BACKGROUND: A dominance of Gag-specific CD8+ T cell responses is significantly associated with a lower viral load in individuals with chronic, untreated clade C human immunodeficiency virus type 1 (HIV-1) infection. This association has not been investigated in terms of Gag-specific CD4+ T cell responses, nor have clade C HIV-1-specific CD4+ T cell epitopes, likely a vital component of an effective global HIV-1 vaccine, been identified. METHODOLOGY/PRINCIPAL FINDINGS: Intracellular cytokine staining was conducted on 373 subjects with chronic, untreated clade C infection to assess interferon-gamma (IFN-gamma) responses by CD4+ T cells to pooled Gag peptides and to determine their association with viral load and CD4 count. Gag-specific IFN-ga...
BACKGROUND: The activity of virus-specific T lymphocytes, among which those capable of a polyfunctio...
OBJECTIVE: To investigate whether there are differences in the virus-specific CD4 T cell response du...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
Background: A dominance of Gag-specific CD8+ T cell responses is significantly associated with a low...
A successful prophylactic vaccine is characterized by long-lived immunity, which is critically depen...
AbstractWe previously detected HIV-1 Gag-specific CD4+ T cells recognizing reference strain viral ep...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
<div><p>CD4+ T cells orchestrate immunity against viral infections, but their importance in HIV infe...
Majority of HIV‐2‐infected individuals meet the criteria of long‐term non‐progressors. This has been...
Cytotoxic T Lymphocytes (CTLs) play a central role in controlling HIV-replication. Although numerous...
Cytotoxic T Lymphocytes (CTLs) play a central role in controlling HIV-replication. Although numerous...
Majority of HIV-2-infected individuals meet the criteria of long-term non-progressors. This has been...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
Knowledge of the most dominant T-cell epitopes in the context of the local human leukocyte antigen (...
Background: Development of AIDS vaccines for effective prevention of circulating HIV-1 is required, ...
BACKGROUND: The activity of virus-specific T lymphocytes, among which those capable of a polyfunctio...
OBJECTIVE: To investigate whether there are differences in the virus-specific CD4 T cell response du...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
Background: A dominance of Gag-specific CD8+ T cell responses is significantly associated with a low...
A successful prophylactic vaccine is characterized by long-lived immunity, which is critically depen...
AbstractWe previously detected HIV-1 Gag-specific CD4+ T cells recognizing reference strain viral ep...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
<div><p>CD4+ T cells orchestrate immunity against viral infections, but their importance in HIV infe...
Majority of HIV‐2‐infected individuals meet the criteria of long‐term non‐progressors. This has been...
Cytotoxic T Lymphocytes (CTLs) play a central role in controlling HIV-replication. Although numerous...
Cytotoxic T Lymphocytes (CTLs) play a central role in controlling HIV-replication. Although numerous...
Majority of HIV-2-infected individuals meet the criteria of long-term non-progressors. This has been...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
Knowledge of the most dominant T-cell epitopes in the context of the local human leukocyte antigen (...
Background: Development of AIDS vaccines for effective prevention of circulating HIV-1 is required, ...
BACKGROUND: The activity of virus-specific T lymphocytes, among which those capable of a polyfunctio...
OBJECTIVE: To investigate whether there are differences in the virus-specific CD4 T cell response du...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...